BIOACTIVATION OF CB 1954 - REACTION OF THE ACTIVE 4-HYDROXYLAMINO DERIVATIVE WITH THIOESTERS TO FORM THE ULTIMATE DNA DNA INTERSTRAND CROSS-LINKING SPECIES

被引:79
作者
KNOX, RJ
FRIEDLOS, F
MARCHBANK, T
ROBERTS, JJ
机构
[1] Molecular Pharmacology Unit, Section of Drug Development, Institute of Cancer Research, Sutton, Surrey SM2 5NG, Cotswold Road
关键词
D O I
10.1016/0006-2952(91)90503-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
5-(Aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is the active form of CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). This hydroxylamine is formed by the bioreduction of CB 1954 by the enzyme DT diaphorase and accounts for the highly selective cytotoxicity of this compound. The reason why the hydroxylamine derivative is so cytotoxic is that, in contrast to CB 1954, it can react difunctionally as characterized by the formation of DNA-DNA interstrand crosslinks in cells treated by this agent. However, although the 4-hydroxylamine compound can produce these crosslinks in cells it cannot crosslink naked DNA (Knox et al., Biochem Pharmacol 37: 4661-4669, 1988). We show here that 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide can become a species capable of binding to DNA and producing interstrand crosslinks, by a direct, non-enzymatic reaction with either acetyl coenzyme A, butyl and propyl coenzyme A or S-acetylthiocholine. Coenzyme A itself cannot produce these effects. The major product of the reaction between the 4-hydroxylamine and thioesters was identified as 4-amino-5-(aziridin-1-yl)-2-nitrobenzamide. However, this compound is not capable of producing the above effects and the major DNA reactive species was a minor product of the reaction. It is proposed that the ultimate, DNA reactive, derivative of CB 1954 is 4-(N-acetoxy)-5-(aziridin-1-yl)-2-nitrobenzamide.
引用
收藏
页码:1691 / 1697
页数:7
相关论文
共 16 条
[1]  
BAILLEUL B, 1981, CANCER RES, V41, P4559
[2]   THE DIFFERENCES IN KINETICS OF RAT AND HUMAN DT DIAPHORASE RESULT IN A DIFFERENTIAL SENSITIVITY OF DERIVED CELL-LINES TO CB-1954 (5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE) [J].
BOLAND, MP ;
KNOX, RJ ;
ROBERTS, JJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (6-7) :867-875
[3]   2,4-DINITRO-5-ETHYLENEIMINOBENZAMIDE (CB 1954) - A POTENT AND SELECTIVE INHIBITOR OF GROWTH OF WALKER CARCINOMA 256 [J].
COBB, LM ;
CONNORS, TA ;
ELSON, LA ;
KHAN, AH ;
MITCHLEY, BC ;
ROSS, WCJ ;
WHISSON, ME .
BIOCHEMICAL PHARMACOLOGY, 1969, 18 (06) :1519-&
[4]  
DEBRAUN JR, 1970, CANCER RES, V30, P577
[5]   THE BINDING OF N-HYDROXY-2-ACETYLAMINOFLUORENE TO DNA AND REPAIR OF THE ADDUCTS IN PRIMARY RAT HEPATOCYTE CULTURES [J].
HOWARD, PC ;
CASCIANO, DA ;
BELAND, FA ;
SHADDOCK, JG .
CARCINOGENESIS, 1981, 2 (02) :97-102
[6]   METABOLISM OF ANTI-TUMOUR AGENT 5-(1-AZIRIDINYL)-2,4-DINITROBENZAMIDE (CB 1954) [J].
JARMAN, M ;
MELZACK, DH ;
ROSS, WCJ .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (22) :2475-2478
[7]  
KING CM, 1974, CANCER RES, V34, P42
[8]   A NEW CYTO-TOXIC, DNA INTERSTRAND CROSSLINKING AGENT, 5-(AZIRIDIN-1-YL)-4-HYDROXYLAMINO-2-NITROBENZAMIDE, IS FORMED FROM 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB-1954) BY A NITROREDUCTASE ENZYME IN WALKER CARCINOMA-CELLS [J].
KNOX, RJ ;
FRIEDLOS, F ;
JARMAN, M ;
ROBERTS, JJ .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4661-4669
[9]   THE NITROREDUCTASE ENZYME IN WALKER CELLS THAT ACTIVATES 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB-1954) TO 5-(AZIRIDIN-1-YL)-4-HYDROXYLAMINO-2-NITROBENZAMIDE IS A FORM OF NAD(P)H DEHYDROGENASE (QUINONE) (EC-1.6.99.2) [J].
KNOX, RJ ;
BOLAND, MP ;
FRIEDLOS, F ;
COLES, B ;
SOUTHAN, C ;
ROBERTS, JJ .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4671-4677
[10]  
KNOX RJ, 1986, CANCER RES, V46, P1972